While at the ChemRar centre in Khimki, the prime minister toured one lab where the biological activity of chemical agents is evaluated. The entire lab is operated by a single robot controlled by one worker. The operator writes a computer programme that tells the robot which substances it needs to mix and the amount of each substance to be used. The robot performs the task, then describes the resulting solution's biological activity.
This robot is capable of selecting 10 solutions out of 10,000 for further pharmaceutical work. As a result, the process of selection takes one day instead of one month.
The prime minister's escort explained that the company is constantly upgrading its equipment and sends its employees abroad to study technological innovations in order to learn how to use them. Mr Putin asked one of the lab workers about his age and background; the researcher said that he was thirty and a PhD. He had worked in Germany for some time but returned to Russia because ChemRar offered better conditions for chemical research and better equipment.
The company develops several kinds of pharmaceuticals, including drugs for schizophrenia, HIV/AIDS, and hepatitis C, as well as vaccines for new types of flu. "You are working on essential medicines," the prime minister said.
ChemRar employs over 400 qualified professionals. It cooperates with major Russian universities, such as Moscow University, the Moscow University of Physics and Technology, and the Mendeleyev University of Chemical Technology, and is eager to involve leading chemists and pharmacists who have experience in Europe or the United States in its research programmes.